Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.24USD
29.19 MUSD
387.22 MUSD
11.74 M
About TORII PHARMACEUTICAL CO
Sector
CEO
Goichi Matsuda
Headquarters
Tokyo
Website
Employees (FY)
583
Founded
1872
ISIN
JP3635800000
FIGI
BBG000BXRMG9
Torii Pharmaceutical Co., Ltd. engages in the manufacturing and marketing of pharmaceutical products. Its products are mainly used for renal diseases and hemodialysis, human immunodeficiency virus (HIV), skin diseases, and allergies. These include Riona, Remitch, Kayexalate, Corectim, Antebate, Cedarcure, and Miticure. The company was founded by Tokubei Torii in 1872 and is headquartered in Tokyo, Japan.
An aggregate view of professional's ratings.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of TRXPF is 24.57 USD — it has decreased by 3.65% in the past 24 hours. Watch Torii Pharmaceutical Co., Ltd stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Torii Pharmaceutical Co., Ltd stocks are traded under the ticker TRXPF.
TRXPF reached its all-time high on Feb 25, 2014 with the price of 33.75 USD, and its all-time low was 19.14 USD and was reached on Mar 8, 2012. View more price dynamics on TRXPF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
TRXPF stock is 3.79% volatile and has beta coefficient of 0.61. Track Torii Pharmaceutical Co., Ltd stock price on the chart and check out the list of the most volatile stocks — is Torii Pharmaceutical Co., Ltd there?
Today Torii Pharmaceutical Co., Ltd has the market capitalization of 649.78 M, it has decreased by 4.08% over the last week.
Yes, you can track Torii Pharmaceutical Co., Ltd financials in yearly and quarterly reports right on TradingView.
Torii Pharmaceutical Co., Ltd is going to release the next earnings report on Jul 31, 2024. Keep track of upcoming events with our Earnings Calendar.
TRXPF net income for the last quarter is 5.80 M USD, while the quarter before that showed 12.41 M USD of net income which accounts for −53.25% change. Track more Torii Pharmaceutical Co., Ltd financial stats to get the full picture.
Torii Pharmaceutical Co., Ltd dividend yield was 3.38% in 2023, and payout ratio reached 81.87%. The year before the numbers were 3.43% and 71.24% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jun 27, 2024, the company has 583.00 employees. See our rating of the largest employees — is Torii Pharmaceutical Co., Ltd on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Torii Pharmaceutical Co., Ltd EBITDA is 48.32 M USD, and current EBITDA margin is 9.65%. See more stats in Torii Pharmaceutical Co., Ltd financial statements.
Like other stocks, TRXPF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Torii Pharmaceutical Co., Ltd stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Torii Pharmaceutical Co., Ltd technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Torii Pharmaceutical Co., Ltd stock shows the sell signal. See more of Torii Pharmaceutical Co., Ltd technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.